Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuyoshi Kirima

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Pharmacological Sciences|January 23, 2004
New methods to evaluate endothelial function: Evaluation of endothelial function by hemoglobin-nitric oxide complex using electron paramagnetic resonance spectroscopyKoichiro Tsuchiya, Kazuyoshi Kirima, Masanori Yoshizumi, et al.
The Biochemical Journal|July 27, 2002
The role of thiol and nitrosothiol compounds in the nitric oxide-forming reactions of the iron-N-methyl-d-glucamine dithiocarbamate complexKoichiro Tsuchiya, Kazuyoshi Kirima, Masanori Yoshizumi, et al.
Experimental Animals|December 25, 2024
Long-term application of MC903 in mice prolongs the characteristic symptoms of atopic dermatitis, such as inflammation, skin barrier dysfunction, and itchingYuya Hoshino, Kazuyoshi Kirima, Naoya Arichika, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2025
Difamilast topically ameliorates pruritus, dermatitis, and barrier dysfunction in atopic dermatitis model mice by inhibiting phosphodiesterase 4, especially the 4B subtypeKazuyoshi Kirima, Yuya Hoshino, Naoya Arichika, et al.
Chemical & Pharmaceutical Bulletin|February 6, 2004
The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radicalShinji Abe, Kazuyoshi Kirima, Koichiro Tsuchiya, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathwayMasanori Yoshizumi, Koichiro Tsuchiya, Yuki Suzaki, et al.
Biochemical Pharmacology|November 6, 2002
Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1)Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 29, 2003
Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NOKazuyoshi Kirima, Koichiro Tsuchiya, Hiroyoshi Sei, et al.
British Journal of Pharmacology|July 30, 2002
Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cellsMasanori Yoshizumi, Toshiaki Kogame, Yuki Suzaki, et al.
Biochimica Et Biophysica Acta|January 20, 2004
Enzymatic and nonenzymatic formation of reactive oxygen species from 6-anilino-5,8-quinolinequinoneToyoshi Hasegawa, Atsushi Bando, Koichiro Tsuchiya, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Pharmacological Sciences|January 23, 2004
New methods to evaluate endothelial function: Evaluation of endothelial function by hemoglobin-nitric oxide complex using electron paramagnetic resonance spectroscopyKoichiro Tsuchiya, Kazuyoshi Kirima, Masanori Yoshizumi, et al.
The Biochemical Journal|July 27, 2002
The role of thiol and nitrosothiol compounds in the nitric oxide-forming reactions of the iron-N-methyl-d-glucamine dithiocarbamate complexKoichiro Tsuchiya, Kazuyoshi Kirima, Masanori Yoshizumi, et al.
Experimental Animals|December 25, 2024
Long-term application of MC903 in mice prolongs the characteristic symptoms of atopic dermatitis, such as inflammation, skin barrier dysfunction, and itchingYuya Hoshino, Kazuyoshi Kirima, Naoya Arichika, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2025
Difamilast topically ameliorates pruritus, dermatitis, and barrier dysfunction in atopic dermatitis model mice by inhibiting phosphodiesterase 4, especially the 4B subtypeKazuyoshi Kirima, Yuya Hoshino, Naoya Arichika, et al.
Chemical & Pharmaceutical Bulletin|February 6, 2004
The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radicalShinji Abe, Kazuyoshi Kirima, Koichiro Tsuchiya, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathwayMasanori Yoshizumi, Koichiro Tsuchiya, Yuki Suzaki, et al.
Biochemical Pharmacology|November 6, 2002
Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1)Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 29, 2003
Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NOKazuyoshi Kirima, Koichiro Tsuchiya, Hiroyoshi Sei, et al.
British Journal of Pharmacology|July 30, 2002
Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cellsMasanori Yoshizumi, Toshiaki Kogame, Yuki Suzaki, et al.
Biochimica Et Biophysica Acta|January 20, 2004
Enzymatic and nonenzymatic formation of reactive oxygen species from 6-anilino-5,8-quinolinequinoneToyoshi Hasegawa, Atsushi Bando, Koichiro Tsuchiya, et al.
Pageof 2